FAB
First American Bank’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.5M | Sell |
126,077
-761
| -0.6% | -$81.7K | 0.93% | 29 |
|
|
2025
Q1 | $12.8M | Sell |
126,838
-3,295
| -3% | -$332K | 0.95% | 31 |
|
|
2024
Q4 | $11.6M | Buy |
130,133
+1,299
| +1% | +$116K | 0.82% | 32 |
|
|
2024
Q3 | $10.8M | Sell |
128,834
-7,988
| -6% | -$669K | 0.78% | 34 |
|
|
2024
Q2 | $10.5M | Buy |
136,822
+1,146
| +0.8% | +$88.3K | 0.79% | 35 |
|
|
2024
Q1 | $9.29M | Buy |
135,676
+4,317
| +3% | +$296K | 0.7% | 36 |
|
|
2023
Q4 | $7.59M | Sell |
131,359
-3,470
| -3% | -$201K | 0.63% | 42 |
|
|
2023
Q3 | $7.12M | Buy |
134,829
+1,297
| +1% | +$68.5K | 0.64% | 42 |
|
|
2023
Q2 | $7.22M | Buy |
133,532
+3,905
| +3% | +$211K | 0.63% | 43 |
|
|
2023
Q1 | $6.49M | Sell |
129,627
-2,012
| -2% | -$101K | 0.59% | 46 |
|
|
2022
Q4 | $6.09M | Buy |
131,639
+5,040
| +4% | +$233K | 0.58% | 49 |
|
|
2022
Q3 | $4.9M | Buy |
126,599
+31,384
| +33% | +$1.22M | 0.51% | 50 |
|
|
2022
Q2 | $3.55M | Buy |
95,215
+1,484
| +2% | +$55.3K | 0.36% | 66 |
|
|
2022
Q1 | $4.15M | Buy |
93,731
+2,369
| +3% | +$105K | 0.35% | 68 |
|
|
2021
Q4 | $3.88M | Buy |
91,362
+1,508
| +2% | +$64.1K | 0.21% | 101 |
|
|
2021
Q3 | $3.9M | Buy |
89,854
+2,137
| +2% | +$92.7K | 0.23% | 97 |
|
|
2021
Q2 | $3.75M | Buy |
87,717
+15,033
| +21% | +$643K | 0.22% | 101 |
|
|
2021
Q1 | $2.81M | Buy |
72,684
+21,088
| +41% | +$815K | 0.18% | 110 |
|
|
2020
Q4 | $1.86M | Buy |
+51,596
| New | +$1.86M | 0.12% | 137 |
|